Health coaching program for adults with type 2 diabetes
The PACT (Patient Activation Through Conversations) Study - A Cluster Randomised Trial of a Health Coach-led Patient Activation Program in Type 2 Diabetes.
This study is testing if a health coaching program can help adults with type 2 diabetes manage their condition better and improve their overall health compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 432 (estimated) |
| Ages | 21 Years to 64 Years |
| Sex | All |
| Sponsor | National Healthcare Group Polyclinics Government |
| Locations | 3 sites (Singapore and 2 other locations) |
| Trial ID | NCT06444074 on ClinicalTrials.gov |
What this trial studies
The PACT Study is a cluster randomized trial that evaluates the effectiveness of a health coaching intervention for adults with sub-optimally controlled type 2 diabetes. Participants will receive personalized coaching from trained laypersons, known as Care Coaches, over a 3-month period, focusing on lifestyle changes and diabetes management. The study compares outcomes such as Glycated Hemoglobin (HbA1c) levels, blood pressure, and quality of life between those receiving the PACT program and those receiving usual care. The trial aims to determine if this intervention can lead to significant improvements in diabetes control and overall health.
Who should consider this trial
Good fit: Ideal candidates are adults aged 21 to 64 with type 2 diabetes and an HbA1c level greater than 8%.
Not a fit: Patients with recent acute coronary syndrome, stroke, or significant social issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve diabetes management and quality of life for patients with type 2 diabetes.
How similar studies have performed: Previous studies have shown positive outcomes with health coaching interventions for diabetes management, suggesting this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals with a diagnosis of Type 2 Diabetes Mellitus who are enrolled in Teamlets in NHGP * Age between 21 to 64 years old * HbA1c level of more than 8% in the last 6 months Exclusion Criteria: * History of acute coronary syndrome in the past 3 months * History of stroke or transient ischaemic attacks in the past 3 months * History of end stage organ failure (liver cirrhosis, cardiac failure, latest eGFR \<30 mL/min/1.73m2 in the last 6 months) * Cancer requiring treatment in the past 5 years. * Active psychiatrist follow up * Social issues that are significant enough for follow-up or referral with a medical social worker within the last 12 months * Women who are pregnant or breastfeeding * Patients who are enrolled in other current diabetes-related interventional studies * Inability to provide written consent for the study protocol and able to commit to the study duration.
Where this trial is running
Singapore and 2 other locations
- NHGP Geylang Polyclinic — Singapore, Singapore (Not_yet_recruiting)
- NHGP Ang Mo Kio Polyclinic — Singapore, Singapore (Not_yet_recruiting)
- NHGP Woodlands Polyclinic — Singapore, Singapore (Recruiting)
Study contacts
- Principal investigator: Sabrina Kay Wye Wong, MBBS — National Healthcare Group Polyclinics
- Study coordinator: Jun Hwee Benjamin Lee, MBBS
- Email: benjamin_jh_lee@nhgp.com.sg
- Phone: +6563553000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.